AstraZeneca's Drug Trial Shows Promising Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy AGX?
Source: CNBC
- Drug Trial Success: AstraZeneca's experimental drug tozorakimab significantly reduced flare-ups in chronic obstructive pulmonary disease cases, leading to a 3% stock increase, with full results expected at an upcoming medical meeting, potentially enhancing the company's competitive edge in respiratory medications.
- Travel Platform Upgrade: Tripadvisor's stock rose 3% after Bank of America upgraded its rating from neutral to buy, citing accelerating activist engagement and rising strategic optionality across its portfolio, reflecting market confidence in its future growth prospects.
- Construction Firm Earnings Beat: Argan's stock surged over 10.5% after reporting fourth-quarter earnings of $3.47 per share and revenue of $262.1 million, both exceeding analyst expectations, indicating strong performance in the construction sector that may attract more investor interest.
- Game Development Platform Forecast: Unity Software's stock jumped over 11% after issuing preliminary first-quarter adjusted EBITDA guidance of $130 million to $135 million, surpassing previous guidance of $105 million to $110 million, suggesting ongoing growth potential in the game development industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AGX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AGX
Wall Street analysts forecast AGX stock price to fall
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 410.850
Low
325.00
Averages
347.50
High
370.00
Current: 410.850
Low
325.00
Averages
347.50
High
370.00
About AGX
Argan, Inc. is a holding company. The Company is a construction firm that conducts operations through its subsidiaries, Gemma Power Systems, LLC and affiliates (GPS), Atlantic Projects Company Limited and affiliates (APC), The Roberts Company, Inc. (TRC), and Southern Maryland Cable, Inc. (SMC). Through GPS and APC, its power industry services, it offers a suite of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector. Through TRC, the industrial construction services provide field services and project management that support new plant construction and additions, maintenance turnarounds, shutdowns and emergency mobilizations for industrial plants. Through SMC, its telecommunications infrastructure services provide project management, construction, installation and maintenance services to commercial, local government and federal government customers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Company Performance: Arganshare's stock has jumped by 25.8% following a strong revenue growth report for Q4.
- Revenue Growth: The significant increase in revenue has positively impacted investor confidence and market performance.
See More
- Strong Quarterly Performance: Argan reported a 13% year-over-year revenue increase to $262 million in its fiscal 2026 fourth quarter, exceeding market expectations and demonstrating robust performance in energy infrastructure amid soaring demand from AI factories.
- Significant Profit Growth: The company's net income surged 57% to $49 million, translating to earnings of $3.47 per share, well above Wall Street's estimate of $1.98, reflecting the nearing completion of projects like the Trumbull Energy Center in Ohio, which boosted profit margins.
- Robust Project Backlog: As of January 31, Argan's project backlog reached $2.9 billion, indicating strong demand for its services, with the CEO noting a robust pipeline of opportunities to build new gas-fired power plants, further solidifying the company's market position.
- Strong Financial Position: With $895 million in cash and investments and no debt, Argan is well-positioned to capitalize on expansion opportunities, particularly in the context of electrification and the replacement of aging power facilities, enhancing its competitive edge in the market.
See More
- Significant Earnings Growth: Argan's revenue rose 13% year-over-year to $262 million in Q4 of fiscal 2026, exceeding Wall Street expectations and demonstrating the company's strong performance in the construction sector.
- Net Income Surge: The company's net income jumped 57% to $49 million, translating to earnings of $3.47 per share, well above analysts' expectations of $1.98, reflecting a substantial improvement in profitability.
- Robust Project Backlog: As of January 31, Argan's project backlog reached $2.9 billion, indicating strong demand for its services, particularly in the growing opportunities for new gas-fired power plants.
- Strong Financial Position: With $895 million in cash and investments and no debt, Argan is well-positioned to capitalize on future expansion opportunities, especially in light of the underinvestment in power infrastructure.
See More
- Impressive Earnings: Argan's Q4 fiscal 2026 report revealed a nearly 13% year-over-year revenue increase to over $262 million, indicating strong demand in the construction, power, and industrial sectors, which solidifies its market position.
- Profitability Surge: Net income soared to $49.2 million ($3.47 per share) from $31.4 million a year ago, surpassing the analyst consensus estimate of $2.13 per share, showcasing significant improvement in profitability.
- Contract Value Growth: The company secured $2.5 billion in new contract value over the year, demonstrating its competitive edge and business expansion capabilities, which are expected to provide robust support for future revenue growth.
- Analyst Optimism: JPMorgan's analyst Michael Fairbanks upgraded Argan's rating from neutral to overweight, setting a price target of $550 per share, reflecting a positive outlook on the company's growth potential, particularly driven by data center construction and AI technology advancements.
See More
- Market Decline: The S&P 500 index fell by 1.67%, marking a 7-month low, while the Nasdaq 100 and Dow Jones Industrial Average dropped by 1.93% and 1.73%, respectively, indicating heightened concerns over economic slowdown.
- Oil Price Surge: WTI crude oil prices surged over 5% due to fears surrounding the Iran conflict, which not only exacerbates inflation expectations but may also compel the Federal Reserve to tighten monetary policy, impacting overall economic growth.
- Consumer Sentiment Drop: The University of Michigan's consumer sentiment index was revised down to 53.3 from 55.5, below the expected 54.0, reflecting a pessimistic outlook among consumers regarding future economic conditions, potentially suppressing consumer spending.
- Escalating US-China Trade Tensions: China launched investigations into US trade practices targeting restrictions on Chinese goods, which could further disrupt global supply chains and increase market uncertainty.
See More










